中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 3
Mar.  2019
Turn off MathJax
Article Contents

Drug-induced liver injury in children:An analysis of medication and clinical features

DOI: 10.3969/j.issn.1001-5256.2019.03.025
Research funding:

 

  • Published Date: 2019-03-20
  • Objective To investigate the drugs responsible for drug-induced liver injury ( DILI) in children and related risk factors, andto provide a reference for safe drug use in children in clinical practice. Methods A retrospective analysis was performed for the clinical da-ta of 187 children with DILI, aged 0-14 years, who were treated in The Fifth Medical Center of Chinese PLA General Hospital from January2008 to December 2017, including medication history, biochemical parameters, symptoms/signs, and clinical outcome. Based on the meth-od of integrated evidence chain, 127 children with medication information were divided into Western medicine-induced DILI group ( West-ern medicine group with 75 children) , traditional Chinese medicine ( TCM) -induced DILI group ( TCM group with 15 children) , and thegroup with DILI induced by Western medicine and TCM ( TCM-Western medicine group with 37 children) . The reason for medication, medication time, latency of DILI, and drug classification were compared between groups. The Kruskal-Wallis H test was used for compari-son of continuous data with skewed distribution between multiple groups, and the Nemenyi test was used for further comparison between twogroups; the chi-square test was used for comparison of categorical data between groups. Results Of all 187 children with DILI, 116 ( 62%) had severe liver injury or above, among whom 3 underwent liver transplantation and 1 died, and 45 ( 24%) developed chronicity.In the Western medicine group and the TCM-Western medicine group, major suspected drugs for DILI were antibiotics, antipyretics, anal-gesics, and anti-inflammatory drugs, which accounted for 42%, 30%, 56%, and 31%, respectively. In the TCM group, the most com-mon TCM drugs for DILI were those used to treat skin diseases, which accounted for 47% and were mainly the preparations of Fallopia multi-flora ( 33%) . There were significant differences between the three groups in medication time ( H = 11. 658, P = 0. 003) and latency ( H =10. 945, P = 0. 004) , and the TCM group had significantly longer medication time and latency than the other two groups ( all P < 0. 05) .Conclusion Most children with DILI have serious conditions. The risk of liver injury due to medication in children should be taken serious-ly, and particular emphasis should be placed on the risk of liver injury caused by antibiotics, antipyretics, analgesics, and anti-inflamma-tory drugs and long-term use of some TCM drugs for skin diseases.

     

  • loading
  • [1] Drug-induced Liver Disease Study Group, Chinese Society ofHepatology, Chinese Medical Association. Guidelines for themanagement of drug-induced liver injury[J]. J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
    [2] GAN Y, DONG Y, ZHANG HF, et al. Clinical characteristicsand outcomes of drug-induced liver injury in children:Astudy of 184 cases[J]. J Clin Hepatol, 2015, 31 (8) :1244-1247. (in Chinese) 甘雨, 董漪, 张鸿飞, 等. 184例儿童药物性肝损伤的临床特征及转归状况评价[J].临床肝胆病杂志, 2015, 31 (8) :1244-1247.
    [3] AMIN MD, HARPAVAT S, LEUNG DH, et al. Drug-inducedliver injury in children[J]. Curr Opin Pediatr, 2015, 27 (5) :625-633.
    [4] FAA G, EKSTROM J, CASTAGNOLA M, et al. A developmen-tal approach to drug-induced liver injury in newborns andchildren[J]. Curr Med Chem, 2012, 19 (27) :4581-4594.
    [5] ZHANG CP, MA Y. Analysis of 29 cases with drug-induced liverinjury in children[J]. J Pediatr Pharm, 2015, 21 (1) :44-47. (inChinese) 张长平, 马燕. 29例儿童药物性肝损伤临床分析[J].儿科药学杂志, 2015, 21 (1) :44-47.
    [6] DU SX, LU LL, MIAO YX, et al. Features of children with drug-induced liver injury:An analysis of 34 cases[J]. J PracHepatol, 2016, 19 (5) :607-609. (in Chinese) 杜水仙, 卢琳琳, 苗英霞, 等.儿童药物性肝损伤34例分析[J].实用肝脏病杂志, 2016, 19 (5) :607-609.
    [7] ZHU XX, WAN CM. Recent progress in management and treat-ment of drug-induced liver injury in children[J]. J Clin Hepa-tol, 2012, 28 (12) :896-898. (in Chinese) 朱欣欣, 万朝敏.儿童药物性肝损害[J].临床肝胆病杂志, 2012, 28 (12) :896-898.
    [8] Branch of Hepatobiliary Diseases, China Association of Chi-nese Medicine, Branch of Chinese Patent Medicine, China As-sociation of Chinese Medicine. Guidelines for the clinical man-agement of herb-induced liver injury[J]. J Clin Hepatol, 2016, 32 (5) :835-843. (in Chinese) 中华中医药学会肝胆病分会, 中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].临床肝胆病杂志, 2016, 32 (5) :835-843.
    [9] WANG JB, MA ZJ, NIU M, et al. Evidence chain-basedcausality identification in herb-induced liver injury:Exemplifi-cation of a well-known liver-restorative herb Polygonum mul-tiflorum[J]. Front Med, 2015, 9 (4) :457-467.
    [10] HE TT, ZHONG XW, ZHANG N, et al. Prospective clinicalstudy of 187 cases with liver damage caused by medicine andits preparations[J]. Chin Hepatol, 2018, 23 (8) :666-669. (in Chinese) 何婷婷, 钟学文, 张宁, 等. 187例中草药及其制剂导致肝损伤病例前瞻性临床研究[J].肝脏, 2018, 23 (8) :666-669.
    [11] ZHU Y, LI YG, WANG JB, et al. Causes, features, and out-comes of drug-induced liver injury in 69 children from China[J]. Gut Liver, 2015, 9 (4) :525-533.
    [12] CHALASANI N, FONTANA RJ, BONKOVSKY HL, et al. Cau-ses, clinical features, and out-comes from a prospectivestudy of drug-induced liver injury in the united states[J].Gastroenterology, 2008, 135 (6) :1924-1934.
    [13] REN ZQ, WANG JH, GUO XY, et al. A review analysis of chi-nese literatures 2005-2014:Clinical features of drug-in-duced liver injury[J]. Chin J Pharmacoepidemiol, 2016, 25 (5) :284-289. (in Chinese) 任张青, 王进海, 郭晓燕, 等. 2005~2014年我国药物性肝损伤临床综合分析[J].药物流行病学杂志, 2016, 25 (5) :284-289.
    [14] QI YB, QIU L, JIANG HL, et al. Clinical characteristics ofdrug-induced liver injury:An analysis of 394 cases[J]. JClin Hepatol, 2014, 30 (5) :438-441. (in Chinese) 祁亚宾, 邱玲, 姜红丽, 等.药物性肝损伤394例临床特点分析[J].临床肝胆病杂志, 2014, 30 (5) :438-441.
    [15] YUAN L, YANG YG, SHEN YX, et al. Research advances indrug-induced liver injury[J]. J Clin Hepatol, 2017, 33 (2) :375-378. (in Chinese) 袁玲, 杨永耿, 沈有秀, 等.药物性肝损伤的研究进展[J].临床肝胆病杂志, 2017, 33 (2) :375-378.
    [16] WANG L. Analysis of the disease composition and householdregistration of hospitalized children in Beijing[J]. Chin MedRecord, 2018, 19 (6) :35-37. (in Chinese) 王丽.北京市住院儿童疾病构成与户籍分析[J].中国病案, 2018, 19 (6) :35-37.
    [17] SQUIRES RH Jr, SHNEIDER BL, BUCUVALAS J, et al. Acuteliver failure in children:The first 348 patients in the pediatric a-cute liver failure study group[J]. J Pediatr, 2006, 148 (5) :652-658.
    [18] MURRAY KF, HADZIC N, WIRTH S, et al. Drug-related hep-atotoxicity and acute liver failure[J]. J Pediatr GastroenterolNutr, 2008, 47 (4) :395-405.
    [19] ZHU Y, LIU SH, WANG JB, et al. Clinical analysis of drug-induced liver injury caused by Polygonum multiflorum and itspreparations[J]. Chin J Integr Tradl Western Med, 2015, 35 (12) :1442-1447. (in Chinese) 朱云, 刘树红, 王伽伯, 等.何首乌及其制剂导致药物性肝损伤的临床分析[J].中国中西医结合杂志, 2015, 35 (12) :1442-1447.
    [20] HE TT, GONG M, BAI YF, et al. Clinical analysis of two diag-nosis methods for herb-induced liver injury[J]. China J ChinMater Med, 2016, 41 (16) :3096-3099. (in Chinese) 何婷婷, 宫嫚, 白云峰, 等. 2种药物性肝损伤诊断指南的应用分析[J].中国中药杂志, 2016, 41 (16) :3096-3099.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1395) PDF downloads(340) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return